drugset / Trial / NCT02602210

Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis

NCT02602210

Phase 3 Terminated 100 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupTriple-blindTreatment

Summary

The main goal of the study is to investigate the clinical relevance, efficacy and safety of treating hypotensive cirrhotic patients with suspicion of sepsis and on vasopressors with low-dose hydrocortisone in order to reverse hemodynamic instability and organ failure and to decrease mortality.

Timeline

Start
2015-01
Primary completion
2020-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 200 mg Intravenous

Indications